Unknown PHASE3 INTERVENTIONAL 2-arm NCT02769754

Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection (HEMOPATCH)

Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection

Sponsor: Instituto de Investigacion Sanitaria La Fe

Conditions Liver Damage Surgery

Interventions Control Hemopatch

Updated 6 times since 2017 Last updated: Feb 14, 2018 Started: May 31, 2016 Primary completion: Feb 28, 2019 Completion: May 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Liver Damage and Surgery, this trial is ongoing. The trial is conducted by Instituto de Investigacion Sanitaria La Fe and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — Jun 2019 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Investigacion Sanitaria La Fe

Data source: Instituto de Investigacion Sanitaria La Fe

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valencia, Spain